(Q38887770)

7 September 2017

Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions (English)

1 reference

7 September 2017

0 references

0 references

Jian Tu

1

1 reference

7 September 2017

Baian Chen

2

1 reference

7 September 2017

Lifeng Yang

3

1 reference

7 September 2017

Kezong Qi

4

1 reference

7 September 2017

Jing Lu

5

1 reference

7 September 2017

Deming Zhao

6

1 reference

7 September 2017

14 April 2015

1 reference

Journal of Molecular Neuroscience

7 September 2017

1 reference

7 September 2017

56

1 reference

7 September 2017

509-518

1 reference

7 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s12031-015-0553-2

7 September 2017

0 references

cites work

Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Delineating common molecular mechanisms in Alzheimer's and prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Self-assembly of Abeta(1-42) into globular neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Fibrillar prion peptide (106-126) and scrapie prion protein hamper phagocytosis in microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Neurotoxicity of a prion protein fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Self-propagation of pathogenic protein aggregates in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Sphingosine Kinase-Dependent Migration of Immature Dendritic Cells in Response to Neurotoxic Prion Protein Fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Neurons and astrocytes respond to prion infection by inducing microglia recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Concomitant Creutzfeldt-Jakob and Alzheimer diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Prion protein codon 129 polymorphism and risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Microglial activation in early stages of amyloid beta protein deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Evaluation of the MTT lymphocyte proliferation assay for the diagnosis of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-015-0553-2

Dendritic cell migration in different micropore filter assays.

21 January 2018

1 reference

12 December 2020

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs

1 reference

12 December 2020

Reactive microglia in Creutzfeldt-Jakob disease

1 reference

12 December 2020

Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases

1 reference

12 December 2020

Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein

1 reference

12 December 2020

Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease.

1 reference

12 December 2020

A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

1 reference

12 December 2020

10.1007/S12031-015-0553-2

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference